Cipla USA, Inc.

Frequent Recalls

7

Recalls

0

Units Recalled

0

Injuries

0

Deaths

Categories: Drug

2026-03-11 to 2026-04-22

Date	Source	Product	Brand	Severity	Units
2026-04-22	FDA Drug	FDA Recall: Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.	Cipla USA, Inc.	Class II	N/A
2026-04-22	FDA Drug	FDA Recall: Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.	Cipla USA, Inc.	Class II	N/A
2026-04-22	FDA Drug	FDA Recall: Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.	Cipla USA, Inc.	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, M	Cipla USA, Inc.	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single	Cipla USA, Inc.	Class II	N/A
2026-03-11	FDA Drug	FDA Recall: Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, I	Cipla USA, Inc.	Class III	N/A
2026-03-11	FDA Drug	FDA Recall: Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., V	Cipla USA, Inc.	Class III	N/A

Cipla USA, Inc. Recalls | WatchRecall